inhibitors - inhibitors Manufacturer Supplier Exporter

Price

Supplier Type

Trader
Manufacturer
contract manufacturer
custom synthesis
Reagent

Supplier Region

Hyderabad(9)
Maharashtra(21)
Gujarat(14)
Tamil Nadu(2)
Mumbai(15)
New Delhi(3)
Beijing(1)
Ahmedabad(5)
Uttar Pradesh(2)
Vadodara(1)
Karnataka(2)
Haryana(1)
Andhra Pradesh(1)

Purity

VETRANAL?, analytical standard
United States Pharmacopeia (USP) Reference Standard
synthetic, ≥90% (HPLC)
solid, ≥98% (HPLC)
solid
Single-chain glycoprotein present in normal serum at about 23 mg/100 ml.
reference standard
recombinant
puriss. p.a., absolute, ≥99.5% (GC)
powder, ≥98% (HPLC)
powder
Potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM).
Pharmaceutical Secondary Standards
pharmaceutical secondary standard, certified reference material
Pharmaceutical Secondary Standard
NLT 95%
N-Acetyl-Leu-Leu-norleucinal, synthetic
Min. 99%
lyophilized powder, ≥95% (SDS-PAGE)
ISOPAC?
InSolution,≥95%
InSolution, ≥99%, 50 mM in DMSO, RI Kinase Inhibitor II, RepSox
InSolution, ≥98%, 5 mg/ml, reversible inhibitor of MAP Kinase Kinase (MEK)
InSolution, ≥98%, 25 mM in DMSO
InSolution, ≥98%, 10 mM, reversible proteasome inhibitor
InSolution, ≥98%, 1 mg/ml, reversible inhibitor of p38 MAP kinase
InSolution, ≥97%, 25 mM in DMSO
InSolution, ≥97%
InSolution, ≥95%, protein kinase C (PKC) inhibitor
InSolution, ≥95%, Inhibitor of protein kinase C
InSolution, ≥95%
Inhibitor of mitosis.
HCl 98%
HCl 97%
HCl 95%
Greater than 99%
European Pharmacopoeia (EP) Reference Standard
Certified Reference Material
bulk package
British Pharmacopoeia (BP) Reference Standard
Batimastat primarily used in Inhibition.
analytical standard
AldrichCPR
A widely used anti-neoplastic agent that also displays immunosuppressant properties.
A potent, cell-permeable, reversible, and selective inhibitor of cyclin-dependent kinases.
A novel anti-neoplastic agent and transcriptional regulator.
A natural metabolite of 17β-estradiol that is devoid of estrogenic activity.
A cell-permeable, potent, reversible proteasome inhibitor (Ki = 4 nM).
A cell-permeable chemically stable cytidine analog that displays antitumor properties.
A broad spectrum potent inhibitor of protein tyrosine phosphatases.
99.99
99.98% trace metals basis
99.5%
≥99.5%
≥99.0% (NT)
99%+
≥99% (TLC), powder
99%
99 %
98+
98.50%
>98.0%(T)(HPLC)
>98.0%(T)
>98.0%(N)
>98.0%(HPLC)(N)
>98.0%(HPLC)
>98.0%(GC)
>98%(GC)(T)
≥98% (TLC)
≥98% (titration)
≥98% (NMR)
≥98% (HPLC), solid
>98% (HPLC), solid
≥98% (HPLC), powder
≥98% (HPLC), Mixture of E & Z isomers, solid
≥98% (HPLC)
>98% (HPLC)
98%
>98%
98 %
97-99 %
>97.0%(HPLC)(N)
>97.0%(HPLC)
>97.0%(GC)(T)
>97.0%(GC)
≥97% (HPLC), solid
≥97% (HPLC), powder
≥97% (HPLC)
97%
>95.0%(HPLC)
≥95%, solid
≥95% (HPLC)
95%
90070559
≥90% (titration)
≥90% (HPLC)
>80.0%(HPLC)
45%
&ge